Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery

INTRODUCTION: The aim of present work was to develop intestinal-targeted pellets of Budesonide, a potent glucocorticoid, used for the treatment of ulcerative colitis and Crohn's disease by extrusion and spheronization method. Current available oral formulations of Budesonide have low efficacy b...

Descripción completa

Detalles Bibliográficos
Autores principales: Raval, Mihir K, Ramani, Riddhi V, Sheth, Navin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853760/
https://www.ncbi.nlm.nih.gov/pubmed/24350040
http://dx.doi.org/10.4103/2230-973X.121294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853760/
https://www.ncbi.nlm.nih.gov/pubmed/24350040
http://dx.doi.org/10.4103/2230-973X.121294

Ejemplares similares